Background illustration for clinical trials search

Oncology Clinical Trials

Browse 8,120 oncology clinical trials enrolling across the United States and Canada. 218 people applied to oncology studies last month. Search by city or state to find one near you.

Filter
1

Los Angeles Prospective GI Biliary and EUS Series

for
Biliary Disease, Pancreatitis, Gastrointestinal Neoplasms
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 0+

Code: NCT02196935

Recruiting

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

for
Cervical Cancer, Endometrial Cancer, Ovarian Epithelial Cancer
Location: Maywood IL
Sponsor: Bital Savir-Baruch

Sex: Female

Age: 18+

Code: NCT03349463

Recruiting

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

for
Glioblastoma
Location: Sherbrooke, Montreal, Ottawa, Toronto, Hamilton,
Sponsor: NovoCure GmbH

Sex: All

Age: 18+

Code: NCT06556563

Phase 3, Recruiting

Using ctDNA to Determine Therapies for Lung Cancer

for
Non Small Cell Lung Cancer, Complete Surgical Resection,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04966663

Phase 2, Recruiting

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

for
Ovarian High Grade Serous Adenocarcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT05998135

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

for
Gallbladder Adenocarcinoma
Location: Morgantown WV
Sponsor: West Virginia University

Sex: All

Age: 18+

Code: NCT05430035

Early Phase 1, Recruiting

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

for
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT04074135

Phase 2, Recruiting

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

for
Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06508463

Phase 1, Recruiting

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

for
Platinum-Resistant Ovarian Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT05225363

Phase 1, Recruiting

Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.

for
Non-Hodgkin Lymphoma
Location: Quebec, Sherbrooke
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Sex: All

Age: 18+

Code: NCT01019863

Phase 2, Recruiting

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

for
Neuroblastoma
Location: Hartford CT, Hershey PA, Durham NC, Miami FL,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT06540963

Phase 2, Recruiting

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

for
Endometrial Cancer, Atypical Hyperplasia,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18 - 41

Code: NCT04008563

Recruiting

A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma

for
Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05055063

Phase 1, Recruiting

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

for
Glioblastoma Multiforme, Astrocytoma, Grade III
Location: Houston TX
Sponsor: David Baskin MD

Sex: All

Age: 18+

Code: NCT03596086

Phase 1, Phase 2, Recruiting

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

for
High Grade Glioma, Glioblastoma
Location: Chandler AZ, Phoenix AZ
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Sex: All

Age: 18+

Code: NCT06072586

Early Phase 1, Recruiting

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

for
Parathyroid Gland Adenoma, Parathyroid Gland Atypical Adenoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03039439

Recruiting

Early Feeding After Oral Cavity Reconstruction

for
Head and Neck Cancer, Free Tissue Transfer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04787939

Recruiting

Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.

for
Lung Cancer
Location: Norfolk VA
Sponsor: Sentara Cardiovascular Research Institute

Sex: All

Age: 20 - 70+

Code: NCT00591552

Recruiting

Computed Tomography (CT) Colonography Versus Optical Colonoscopy

for
Colonic Neoplasia
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19 - 65

Code: NCT01181739

Recruiting

Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer

for
Pancreatic Cancer
Location: Boston MA, Hartford CT, Charlottesville VA, Houston TX,
Sponsor: Craig L Slingluff, Jr

Sex: All

Age: 18+

Code: NCT02305186

Phase 1, Phase 2, Recruiting

What is oncology?

Oncology is the branch of medicine focused on cancer. Cancer itself is not a single disease. It is a family of more than 100 diseases, from breast cancer and lung cancer to blood cancers like leukemia and lymphoma. What they share is the same basic problem: cells that grow and divide without stopping. About 4 in 10 people in the US will be diagnosed with some form of cancer during their lifetime.

Cancer research moves faster than almost any other field of medicine. Cancer drugs made up about 35% of all new FDA drug approvals in 2025, 16 new medicines in one year. The 5 year survival rate for all cancers combined reached 70% for people diagnosed in 2015 to 2021, a first in US history. And survival for metastatic (spread) cancer has doubled since the mid 1990s, from 17% to 35%. Every one of those gains came through clinical trials.

Who can participate in oncology trials?

Do oncology trial participants get paid?

Types of cancer clinical trials

The stages of cancer, and why they matter for trials

How to enroll in a clinical trial for cancer